The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Impact of the recurrence score (RS) result and mismatch repair status (MMR) on agreement between oncologists (MDs) for stage II colon cancer (CC) recurrence risk (RR) assessment: A novel clinical utility endpoint for prognostic markers.
Robin Katie Kelley
Consultant or Advisory Role - Genomic Health (U)
Research Funding - Genomic Health
Margarita Lopatin
Employment or Leadership Position - Genomic Health
Stock Ownership - Genomic Health
Jimmy Hwang
No relevant relationships to disclose
Michael Crager
Employment or Leadership Position - Genomic Health
Adrienne A Brenner
No relevant relationships to disclose
Jane Kuczma
Employment or Leadership Position - Genomic Health
Stock Ownership - Genomic Health
Ashley King
Employment or Leadership Position - Genomic Health
Stock Ownership - Genomic Health
Calvin Chao
Employment or Leadership Position - Genomic Health
Stock Ownership - Genomic Health
Mark Lee
Employment or Leadership Position - Genomic Health
Stock Ownership - Genomic Health
Alan Paul Venook
Research Funding - Genomic Health